List view / Grid view

Hepatitis C (HCV)



AbbVie receives CHMP positive opinion for Hep C tablet combination

2 March 2017 | By Niamh Marriott, Digital Editor

The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for Abbvie’s shorter, eight-week treatment of Viekirax (ombitasvir/paritaprevir/ritonavir tablets) + Exviera (dasabuvir tablets) as an option for previously untreated adult patients with geotype 1b chronic hepatitis C virus (HCV)…


H is for Hepatitis C

23 November 2016 | By Niamh Louise Marriott, Digital Content Producer

H is for Hepatitis C - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in Hep C research...